Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,438 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for
Breast Cancer, Metastatic
Location: Seattle WA, Portland OR, Billings MT, Grand Junction CO,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase2, Recruiting

Long COVID-19 and MAB Study

for
COVID-19
Location: Tacoma WA
Sponsor: MultiCare Health System Research Institute

Sex: All

Age: 18+

Code: NCT05508295

Recruiting

ELEVATE-HFpEF Clinical Study

for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Tacoma WA, Vancouver, Calgary, San Francisco CA,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Sex: All

Age: 40+

Code: NCT06678841

Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Tacoma WA, Seattle WA, Salem OR, Stockton CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07091019

Recruiting
Active & Responsive

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

for
Primary Sclerosing Cholangitis (PSC)
Location: Seattle WA, Iowa City IA, Nashville TN, Baltimore MD
Sponsor: LISCure Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06699121

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Caloric Balance Markers Study

for
Metabolism
Location: Seattle WA
Sponsor: Institute for Systems Biology

Sex: All

Age: 18+

Code: NCT07141537

Not recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Tacoma WA, Kelowna, Spokane WA, Edmonton, Fair Oaks CA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting
Featured

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: Seattle WA, Portland OR, East Brunswick NJ,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07525206

Phase3, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Seattle WA, Vancouver WA, Duarte CA, Irvine CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07155187

Phase2, Phase3, Recruiting
Featured

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Seattle WA, Beverly Hills CA, Denver CO, St Louis MO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06896916

Phase1, Recruiting
Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Tacoma WA, Seattle WA, Boise ID, Calgary, Edmonton,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase2, Recruiting
Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Tacoma WA, Olympia WA, Eugene OR, Clovis CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for
Bipolar I Disorder, Bipolar II Disorder
Location: Bellevue WA, Everett WA, Sherman Oaks CA, Montclair CA,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase2, Recruiting
FeaturedActive & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder (GAD)
Location: Bellevue WA, Everett WA, Walnut Creek CA, Las Vegas NV,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase2, Recruiting
FeaturedActive & Responsive

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

for
Bipolar I or II Disorder
Location: Bellevue WA, Everett WA, Portland OR, Walnut Creek CA,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07220460

Phase2, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Squamous Non-Small Cell Lung Cancer
Location: Seattle WA, Reno NV, Los Angeles CA, Newport Beach CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07005102

Phase2, Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

for
Major Depressive Disorder
Location: Bellevue WA, Everett WA, Walnut Creek CA, Las Vegas NV,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07276997

Phase2, Recruiting
FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Renton WA, Spokane WA, Butte MT, Reno NV,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

for
Schizophrenia, Bipolar I Disorder
Location: Everett WA, Denver CO, Little Rock AR, Cincinnati OH,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 12 - 17

Code: NCT05648591

Recruiting

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

for
Schizophrenia, Bipolar I Disorder
Location: Everett WA, Stanford CA, Lincoln NE, Saint Charles MO,
Sponsor: Alkermes, Inc.

Sex: All

Age: 10 - 17

Code: NCT05303064

Phase3, Recruiting